Deep Intracochlear Injection of Triamcinolone-acetonide with an Inner Ear Catheter in Patients with Residual Hearing

Overview

Journal Front Neurosci

Date 2023 Aug 11

PMID 37564369

Authors

Nils K Prenzler

Rolf Salcher

Thomas Lenarz

Lutz Gaertner

Anke Lesinski-Schiedat

Athanasia Warnecke

Affiliations

Soon will be listed here.

Abstract

Introduction: In a previous study, an inner ear catheter was used to deliver low- and high-dose steroids into the cochlea prior to cochlear implant electrode insertion. With this approach, more apical regions of the cochlea could be reached and a reduction of electrode impedances in the short term was achieved in cochlear implant recipients. Whether intracochlear application of drugs via the catheter is a safe method also for patients with residual hearing has not been investigated hitherto. The aim of the present study was therefore to investigate the effect of intracochlear triamcinolone application in cochlear implant recipients with residual hearing.

Patients And Methods: Patients with residual hearing were administered triamcinolone-acetonide (4 mg/ml; = 10) via an inner ear catheter just prior to insertion of a MED-EL FLEX28 electrode. Impedances were measured at defined time points (intra-operatively, post-operatively and at first fitting) and retrospectively compared with a control group (no steroid application) and low- and high-dose group. Hearing thresholds were measured preoperatively, 3 days after surgery and at first fitting by pure tone audiometry. Pre- to postoperative hearing loss was determined at first fitting and compared to results from a previous study.

Results: The median hearing loss after implantation (125-1,500 Hz) was 20.6 dB. Four patients (40%) showed a median hearing loss of less than 15 dB, three patients (30%) between 15 and 30 dB and three patients (30%) more than 30 dB. The median hearing loss was similar to the results obtained from our previous study showing a median hearing loss of 24 dB when using FLEX28 electrode arrays.

Conclusion: No difference in residual hearing loss was found when comparing application of triamcinolone-acetonide using an inner ear catheter prior to the insertion of a FLEX28 electrode array to the use of the FLEX28 electrode array without the catheter. Thus, we conclude that application of drugs to the cochlea with an inner ear catheter could be a feasible approach in patients with residual hearing.

Citing Articles

Preclinical evaluation of a hydraulic actuation system with guide tube for robotic cochlear implant electrode insertion.

Cramer J, Salcher R, Frohlich M, Bottcher-Rebmann G, Artukarslan E, Lenarz T Biomed Eng Online. 2025; 24(1):19.

PMID: 39953541 PMC: 11829445. DOI: 10.1186/s12938-025-01338-z.

Drug selection for inner ear therapy.

Salt A, Turner J Front Pharmacol. 2024; 15:1452927.

PMID: 39484167 PMC: 11525065. DOI: 10.3389/fphar.2024.1452927.

Insertion trauma of a novel inner ear catheter for intracochlear drug delivery.

Gerlitz M, Yildiz E, Gadenstaetter A, Niisuke K, Kandathil S, Nieratschker M Front Vet Sci. 2024; 11:1397554.

PMID: 38903692 PMC: 11188737. DOI: 10.3389/fvets.2024.1397554.

References

Salt A, Hartsock J, Hou J, Piu F . Comparison of the Pharmacokinetic Properties of Triamcinolone and Dexamethasone for Local Therapy of the Inner Ear. Front Cell Neurosci. 2019; 13:347. PMC: 6689996. DOI: 10.3389/fncel.2019.00347. View

Manrique-Huarte R, Alvarez De Linera-Alperi M, Parilli D, Rodriguez J, Borro D, Dueck W . Inner ear drug delivery through a cochlear implant: Pharmacokinetics in a Macaque experimental model. Hear Res. 2021; 404:108228. DOI: 10.1016/j.heares.2021.108228. View

Pillsbury 3rd H, Dillon M, Buchman C, Staecker H, Prentiss S, Ruckenstein M . Multicenter US Clinical Trial With an Electric-Acoustic Stimulation (EAS) System in Adults: Final Outcomes. Otol Neurotol. 2018; 39(3):299-305. PMC: 5821485. DOI: 10.1097/MAO.0000000000001691. View

Lenarz T . [Cochlear Implant - State of the Art]. Laryngorhinootologie. 2017; 96(S 01):S123-S151. DOI: 10.1055/s-0043-101812. View

Santa Maria P, Gluth M, Yuan Y, Atlas M, Blevins N . Hearing preservation surgery for cochlear implantation: a meta-analysis. Otol Neurotol. 2014; 35(10):e256-69. DOI: 10.1097/MAO.0000000000000561. View

Adunka O, Buss E, Clark M, Pillsbury H, Buchman C . Effect of preoperative residual hearing on speech perception after cochlear implantation. Laryngoscope. 2008; 118(11):2044-9. DOI: 10.1097/MLG.0b013e3181820900. View

Dorman M, Gifford R . Combining acoustic and electric stimulation in the service of speech recognition. Int J Audiol. 2010; 49(12):912-9. PMC: 2992956. DOI: 10.3109/14992027.2010.509113. View

Sargsyan G, Kanaan N, Lenarz T, Lesinski-Schiedat A . Comparison of speech recognition in cochlear implant patients with and without residual hearing: A review of indications. Cochlear Implants Int. 2021; 22(5):257-264. DOI: 10.1080/14670100.2021.1898111. View

Sheffield S, Jahn K, Gifford R . Preserved acoustic hearing in cochlear implantation improves speech perception. J Am Acad Audiol. 2015; 26(2):145-54. PMC: 4446708. DOI: 10.3766/jaaa.26.2.5. View

10.

Salt A, Plontke S . Steroid Nomenclature in Inner Ear Therapy. Otol Neurotol. 2020; 41(6):722-726. PMC: 7384350. DOI: 10.1097/MAO.0000000000002624. View

11.

Shew M, Walia A, Durakovic N, Valenzuela C, Wick C, McJunkin J . Long-term Hearing Preservation and Speech Perception Performance Outcomes With the Slim Modiolar Electrode. Otol Neurotol. 2021; 42(10):e1486-e1493. DOI: 10.1097/MAO.0000000000003342. View

12.

Warnecke A, Staecker H, Rohde E, Gimona M, Giesemann A, Szczepek A . Extracellular Vesicles in Inner Ear Therapies-Pathophysiological, Manufacturing, and Clinical Considerations. J Clin Med. 2022; 11(24). PMC: 9788356. DOI: 10.3390/jcm11247455. View

13.

Gantz B, Hansen M, Dunn C . Clinical perspective on hearing preservation in cochlear implantation, the University of Iowa experience. Hear Res. 2022; 426:108487. PMC: 9482999. DOI: 10.1016/j.heares.2022.108487. View

14.

Suhling M, Majdani O, Salcher R, Leifholz M, Buchner A, Lesinski-Schiedat A . The Impact of Electrode Array Length on Hearing Preservation in Cochlear Implantation. Otol Neurotol. 2016; 37(8):1006-15. DOI: 10.1097/MAO.0000000000001110. View

15.

Yildiz E, Gadenstaetter A, Gerlitz M, Landegger L, Liepins R, Nieratschker M . Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics. Front Pharmacol. 2023; 14:1062379. PMC: 10034346. DOI: 10.3389/fphar.2023.1062379. View

16.

Skarzynska M, Kolodziejak A, Gos E, Skarzynski P . The Clinical Effects of Steroids Therapy in the Preserving Residual Hearing after Cochlear Implantation with the OTICON Neuro Zti EVO. J Clin Med. 2021; 10(13). PMC: 8269171. DOI: 10.3390/jcm10132868. View

17.

Ibrahim H, Helbig S, Bossard D, Truy E . Surgical trauma after sequential insertion of intracochlear catheters and electrode arrays (a histologic study). Otol Neurotol. 2011; 32(9):1448-54. DOI: 10.1097/MAO.0b013e318238264d. View

18.

Salt A, Hartsock J, Gill R, Smyth D, Kirk J, Verhoeven K . Perilymph pharmacokinetics of marker applied through a cochlear implant in guinea pigs. PLoS One. 2017; 12(8):e0183374. PMC: 5560723. DOI: 10.1371/journal.pone.0183374. View

19.

Rajan G, Tavora-Vieira D, Baumgartner W, Godey B, Muller J, ODriscoll M . Hearing preservation cochlear implantation in children: The HEARRING Group consensus and practice guide. Cochlear Implants Int. 2017; 19(1):1-13. DOI: 10.1080/14670100.2017.1379933. View

20.

Prenzler N, Salcher R, Lenarz T, Gaertner L, Warnecke A . Dose-Dependent Transient Decrease of Impedances by Deep Intracochlear Injection of Triamcinolone With a Cochlear Catheter Prior to Cochlear Implantation-1 Year Data. Front Neurol. 2020; 11:258. PMC: 7194199. DOI: 10.3389/fneur.2020.00258. View